drugset / Trial / NCT00004404

Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

NCT00004404

Completed 20 enrolled Boston Children's Hospital
Treatment

Summary

OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.

Timeline

Start
1997-04
Primary completion
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Clotrimazole Unknown Oral
Subject Hydroxyurea Other / unclassified Oral

Indications